CD155 promotes the progression of colorectal cancer by restraining CD8

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Dongbing Ding, Yiquan Li, Rongpu Liang, Liting Liu, Jiannan Ren, Bo Wei

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: Germany : Cancer immunology, immunotherapy : CII , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 737537

BACKGROUND: CD155 is a crucial factor in the regulation of T cell function and contributes to immune escape. CD155 upregulation has been found in several types of cancer. However, the mechanism by which CD155 regulates CD8 METHODS: We studied the expression of CD155 in colorectal cancer tissues through western blot, immunohistochemistry, and the TCGA database. We verified the effects of CD155 on the functions of colorectal cancer cells and CD8 RESULTS: We demonstrated that stable CD155 expression was negatively correlated with prognosis in colorectal cancer patients. In vitro experiments confirmed that CD155 does not affect tumor cell proliferation, migration, or invasion. We also revealed that CD155 downregulated the function and migration of CD8 CONCLUSION: This study revealed that CD155 can promote the progression of colorectal cancer by regulating the PI3K / AKT-NF-κB pathway to promote the depletion of CD8
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH